Značajna supresija aldosterona deksametazonom
Medicinski glasnik
E-mail
bovamed@gmail.com
Ustanova
Klinika za endokrinologiju, dijabetes i bolesti metabolizma, Univerzitetski klinički centar Srbije
Medicinski fakultet Univerziteta u Beogradu, Srbija
Ključne reči
Reference
Elston MS, Boyle V, Conaglen JV, et al. Genetic testing for familial hyperaldosteronism type 1 in Aotearoa/New Zealand. Intern Med J. 2024;54(11):1814-1820. doi:10.1111/ imj.16511.
Mulatero P, Araujo-Castro M, Pacak K, et al. Familial hyperaldosteronism: an European Reference Network on Rare Endocrine Conditions clinical practice guideline. Eur J Endocrinol. 2024;190(4):G1-G12. doi:10.1093/ejendo/lvae029
Zeman J, Veldhuisen DJ, Kamilaris C, et al. Glucocorticoid Remediable Aldosteronism in a Family with a Strong History of Cerebral Aneurysms and Hypertension. Prague Med Rep. 2025;126(3):151-154. doi:10.14712/23362936.2025.23.
Sažetak
Značajna supresija aldosterona deksametazonom
| Preuzmi | Veličina |
|---|---|
| 08 - 108-112 Medicinski glasnik 100_0.pdf (221.87 KB) | 221.87 KB |